Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery

Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery

Objective: Medullary thyroid carcinoma (MTC) is a rare malignancy secreting calcitonin (Ctn). We aimed to analyze the relationship between Ctn levels at different time points in patients with MTC, and evaluate its predictive effect on recurrence. Methods: A retrospective study of patients diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fengli Guo, Lijuan Li, Pengfei Gu, Guoqiang Zhang, Xianhui Ruan, Jingzhu Zhao, Xiangqian Zheng, Songfeng Wei, Ming Gao
Formato:	Artículo
Lenguaje:	English
Publicado:	Elsevier 2024-04-01
Colección:	Heliyon
Materias:	Medullary thyroid carcinoma Calcitonin Normalization of calcitonin Biochemical cure Disease-free survival
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2405844024058882

Ejemplares similares

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Wenliang Yue, et al.
Publicado: (2022-11-01)

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma
por: Fengli Guo, et al.
Publicado: (2024-05-01)

Calcitonin receptor expression in medullary thyroid carcinoma
por: Virginia Cappagli, et al.
Publicado: (2017-09-01)

Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update
por: Liu S, et al.
Publicado: (2024-04-01)

Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence
por: Qiaodan Zhu, et al.
Publicado: (2021-04-01)

Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
por: LI Rui, LIU Zhuoran, YAN Jiqi
Publicado: (2022-06-01)

To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.
por: Rosaria Ruggeri, et al.
Publicado: (2018-12-01)

Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
por: Pierpaolo Trimboli, et al.
Publicado: (2018-06-01)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
por: Rafael Loch Batista, et al.
Publicado: (2013-01-01)

Diagnosis and treatment of medullary thyroid carcinoma-an update
por: CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben
Publicado: (2022-06-01)

Metastatic medullary thyroid carcinoma: A case report
por: Mitra Niafar, et al.
Publicado: (2011-01-01)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
por: Sun Jung Kim, et al.
Publicado: (2021-11-01)

Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy
por: Yixuan Song, et al.
Publicado: (2024-09-01)

Breast metastasis from medullary thyroid carcinoma: a report of a case
por: Yoko Omi, et al.
Publicado: (2021-08-01)

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer
por: Stéphane Bardet, et al.
Publicado: (2023-01-01)

The role of procalcitonin in the follow-up of medullary thyroid cancer
por: Jacopo Manso, et al.
Publicado: (2023-01-01)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
por: Claudio Gambardella, et al.
Publicado: (2019-05-01)

Small cell medullary thyroid carcinoma: A diagnostic dilemma
por: Anuj Verma, et al.
Publicado: (2017-01-01)

Critically evaluated key points on hereditary medullary thyroid carcinoma
por: Daqi Zhang, et al.
Publicado: (2024-06-01)

Analysis of some prognostic factors significance for medullary thyroid cancer metastasis
por: V.O. Palamarchuk, et al.
Publicado: (2022-03-01)

Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer
por: Il Youb Jeong, et al.
Publicado: (2024-08-01)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
por: Hyunju Park, et al.
Publicado: (2021-10-01)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
por: Daqi Zhang, et al.
Publicado: (2022-07-01)

Clinicopathological characteristics and prognostic analysis of medullary thyroid carcinoma in children and adolescents
por: LIU Wei , WANG Xiaojiang , ZHANG Jing , ZHU Weifeng , PENG Fengying , WANG Jianchao , XIAO Weijin , HU Dan
Publicado: (2021-11-01)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
por: Zan Jiao, et al.
Publicado: (2022-12-01)

Cytodiagnosis of medullary carcinoma thyroid- role of FNAC and serum calcitonin- A case report
por: Majed B Momin, et al.
Publicado: (2018-01-01)

SPORADIC MEDULLARY THYROID CANCER. СASE REPORT
por: L. A. Ivanova, et al.
Publicado: (2015-04-01)

Calcitonin‐secreting pancreatic neuroendocrine tumor in a patient with elevated thyroid fine‐needle aspirate calcitonin washout: A case report and review of the literature
por: Darryl Mason, et al.
Publicado: (2022-01-01)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
por: Clotilde Sparano, et al.
Publicado: (2023-02-01)

A rare case of medullary carcinoma
por: O.Z. Lishchuk, et al.
Publicado: (2023-10-01)

Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
por: E. V. Ryabchenko
Publicado: (2022-06-01)

Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study
por: Daqi Zhang, et al.
Publicado: (2024-01-01)

Diagnosis and treatment of medullary thyroid carcinoma: A case report
por: Xin Nie, et al.
Publicado: (2023-11-01)

Medullary carcinoma of thyroid: Case report and a review of literature
por: Ratna Priya, et al.
Publicado: (2016-01-01)

Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer
por: Samantha M. Siskind, MD, et al.
Publicado: (2024-11-01)

Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma
por: Pierpaolo Trimboli, et al.
Publicado: (2024-01-01)

Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”
por: N. V. Severskaya, et al.
Publicado: (2022-08-01)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
por: Sena Turkdogan, et al.
Publicado: (2018-09-01)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
por: Muhammed Erkam Sencar, et al.
Publicado: (2022-02-01)

Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature
por: Adnan Zaina, et al.
Publicado: (2013-01-01)